Socioeconomic Status and Stroke Incidence, Prevalence, Mortality and Worldwide Burden: An Ecological Analysis from the Global Burden of Disease Study ۲۰۱۷

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 76

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_QJVC-2-1_046

تاریخ نمایه سازی: 24 آبان 1401

Abstract:

Background and Aim: Socioeconomic status (SES) is associated with stroke incidence and mortality. Distribution of stroke risk factors is changing worldwide; evidence on these trends is crucial to the allocation of resources for prevention strategies to tackle major modifiable risk factors with the highest impact on stroke burden. Materials and Methods: We extracted data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) ۲۰۱۷. We analysed trends in global and SES-specific age-standardised stroke incidence, prevalence, mortality, and disability-adjusted life years (DALYs) lost from ۱۹۹۰ to ۲۰۱۷. We also estimated the age-standardised attributable risk of stroke mortality associated with common risk factors in low-, low-middle-, upper-middle, and high-income countries. Further, we explored the effect of age and sex on associations of risk factors with stroke mortality from ۱۹۹۰ to ۲۰۱۷. Results: Despite a growth in crude number of stroke events from ۱۹۹۰ to ۲۰۱۷, there has been an ۱۱.۳% decrease in age-standardised stroke incidence rate worldwide (۱۵۰.۵, ۹۵% uncertainty interval [UI] ۱۴۰.۳–۱۶۱.۸ per ۱۰۰,۰۰۰ in ۲۰۱۷). This has been accompanied by an overall ۳.۱% increase in age-standardised stroke prevalence rate (۱۳۰۰.۶, UI ۱۲۲۹.۰–۱۳۷۴.۷ per ۱۰۰,۰۰۰ in ۲۰۱۷), and a ۳۳.۴% decrease in age-standardised stroke mortality rate (۸۰.۵, UI ۷۸.۹–۸۲.۶ per ۱۰۰,۰۰۰ in ۲۰۱۷) over the same time period. The rising trends in age-standardised stroke prevalence have been observed only in middle-income countries, despite declining trends in age-standardised stroke incidence and mortality in all income categories since ۲۰۰۵. Further, there has been almost a ۳۴% reduction in stroke death rate (۶۷.۸, UI ۶۴.۱–۷۱.۱ per ۱۰۰,۰۰۰ in ۲۰۱۷) attributable to modifiable risk factors, more prominently in wealthier countries. Conclusion: Almost half of stroke-related deaths are attributable to poor management of modifiable risk factors, and thus potentially preventable. We should appreciate societal barriers in lower-SES groups to design tailored preventive strategies. Despite improvements in general health knowledge, access to healthcare, and preventative strategies, SES is still strongly associated with modifiable risk factors and stroke burden, thus screening of people from low SES at higher stroke risk is crucial.

Keywords:

Global burden of disease , Socioeconomic factors , Stroke

Authors

Abolfazl Avan

Department of Neurology, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Hadi Digaleh

Neurobiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mario Di Napoli

Neurological Service, San Camillo de’ Lellis General Hospital, Rieti, Italy

Saverio Stranges

Department of Epidemiology & Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada

Reza Behrouz

۷ Stroke Program, Department of Neurology, School of Medicine, University of Texas Health Science Center, San Antonio, TX

Golnaz Shojaeianbabaei

Department of Neurology, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Amin Amiri

Department of Neurology, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Reza Tabrizi

Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

Naghmeh Mokhber

Department of Psychiatry & Behavioural Neurosciences, Western University, London, Ontario, Canada

David J. Spence

Division of Clinical Pharmacology, Western University, London, Ontario, Canada

Mahmoud Reza Azarpazhooh

۱Department of Clinical Neurological Science, Western University, London, Ontario, Canada